Shares of Inovio Pharmaceuticals Inc. INO, -6.43% slid 6.43% to $3.20 Thursday, on what proved to be an all-around rough trading session for the stock market, with the NASDAQ Composite Index COMP, -2.14% falling 2.14% to 13,351.08 and Dow Jones Industrial Average DJIA, -0.33% falling 0.33% to 34,451.23. The stock’s fall snapped a two-day winning streak. Inovio Pharmaceuticals Inc. closed $7.17 below its 52-week high ($10.37), which the company achieved on April 15th.
The stock underperformed when compared to some of its competitors Thursday, as AbbVie Inc. ABBV, +2.11% rose 2.11% to $162.31, Amgen Inc. AMGN, +0.20% rose 0.20% to $254.02, and AstraZeneca PLC ADR AZN, +0.12% rose 0.12% to $69.05. Trading volume (2.9 M) remained 1.9 million below its 50-day average volume of 4.8 M.